Company Filing History:
Years Active: 2023-2025
Title: Claudia Racioppi: Innovator in Tauopathy Research
Introduction
Claudia Racioppi is a prominent inventor based in New York, NY, known for her significant contributions to the field of tauopathy research. With a total of three patents to her name, she has made remarkable strides in understanding the genetic factors that influence tau aggregation.
Latest Patents
Her latest patents focus on models of tauopathy, specifically identifying the genes BANF1, PPP2CA, and ANKLE2 as critical players in promoting tau aggregation when disrupted. These patents provide improved tauopathy models, including cells, tissues, or animals that exhibit mutations or inhibited expression of these genes. Furthermore, her work outlines methods for utilizing these improved models to assess therapeutic candidates for treating tauopathies, as well as techniques for accelerating or exacerbating tau aggregation in these models.
Career Highlights
Claudia Racioppi is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in tauopathy. Her innovative approaches have positioned her as a key figure in the development of therapeutic strategies for neurodegenerative diseases.
Collaborations
Throughout her career, Claudia has collaborated with notable colleagues, including Marine Prissette and Mathieu Desclaux. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for tauopathies.
Conclusion